1. ALLA AKTIER
  2. NYHETER
  3. LIPUM

Lipum

Nyheter Lipum Nyheter alla bolag

Lipum to participate in following upcoming

Lipum (publ), a clinical stage biopharmaceutical company focused on chronic inflammatory diseases, today announced its participation in the following upcoming events.

BioStock Investor Meeting, 20 September, Stockholm, Sweden

Redeye theme: Autoimmune and Inflammatory Disease, 3 October, Stockholm, Sweden

Småbolagsdagen i Lund, Aktiespararna, 9 October, Lund, Sweden

BIO-Europe, 6–8 November, München, Germany

Umeå på börsen, 14 November, Umeå, Sweden

Redeye Life Science Day, 23 November 2023, Stockholm, Sweden

Nordic Life Science Days, 29-30 November 2023, Copenhagen, Denmark

"I look forward to these meetings. Our clinical study of the drug candidate SOL-116 is ongoing and the industry meetings provide great opportunities to present our progress.", says CEO Einar Pontén.

Contacts
Einar Pontén, CEO
einar.ponten@lipum.se
+46 70 578 34 95
Web: www.lipum.se

About Us
Lipum AB (publ) is a clinical stage biopharmaceutical company specialized in discovery and development of a novel treatment for chronic inflammatory diseases. The lead candidate SOL-116 is a humanized antibody designed to provide efficacious therapy by blocking a previously overlooked target molecule of the immune system (BSSL). SOL-116 is in clinical stage supported by solid data for rheumatoid arthritis. Lipum also explores other inflammatory diseases with a high unmet medical need. The company is based in Umeå, an excellent life science cluster in Sweden. Lipum’s unique approach has attracted international attention, including a major European Commission Horizon 2020 grant. The company's share (LIPUM) is traded on the Nasdaq First North Growth Market. Certified Adviser is G&W Fondkommission.

Attachments
Lipum to participate in following upcoming

Datum 2023-09-13, kl 08:45
Källa MFN
Bifogade filer
Lipum to participate in following upcoming
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!